08/15/2025
In a bold move that underscores a growing trend across professional sports, the Philadelphia Phillies have expanded their partnership with NexGen Hyperbaric into a multi-year agreement, becoming the first Major League Baseball organization to fully integrate a mobile hyperbaric medicine platform into its player health and performance strategy.
Since launching the partnership, the Phillies have successfully incorporated NexGen's on-site hyperbaric oxygen therapy (HBOT) unit into their recovery and rehabilitation protocols. Players have experienced noticeable improvements in recovery and overall readiness, contributing to more consistent performance.
"Our players have reported feeling the benefits from their HBOT treatments," said Paul Buchheit, Head Athletic Trainer for the Philadelphia Phillies. "We have also measured in a small sample observed measurable improvements in recovery as well as adjunctive benefits in players' return from injury. NexGen's professionalism, clinical safety and rigor, and responsiveness make them a trusted extension of our medical operation."
Unlike fixed hospital-based systems, NexGen Hyperbaric's proprietary mobile platform was engineered specifically for elite sports environments. It delivers 100% medical-grade oxygen in advanced monoplace hyperbaric chambers under the oversight of licensed clinical professionals—all without disrupting training schedules or travel logistics.
"Our solution is purpose-built for teams like the Phillies who are committed to innovation in player care," said Jonathan Rotella, President and CEO of NexGen Hyperbaric. "It's efficient, scalable, and designed to meet the rigorous demands of professional sports. We're proud to set a precedent in Major League Baseball and honored to work with such a forward-thinking medical team."
The success of this integration signals a wider shift in how professional teams are approaching injury recovery, inflammation management, and long-term performance optimization.
